PMID- 25582786 OWN - NLM STAT- MEDLINE DCOM- 20151021 LR - 20240323 IS - 1872-7972 (Electronic) IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 601 DP - 2015 Aug 5 TI - Spine synapse remodeling in the pathophysiology and treatment of depression. PG - 20-9 LID - S0304-3940(15)00027-0 [pii] LID - 10.1016/j.neulet.2015.01.022 [doi] AB - Clinical brain imaging and postmortem studies provide evidence of structural and functional abnormalities of key limbic and cortical structures in depressed patients, suggesting that spine synapse connectivity is altered in depression. Characterization of the cellular determinants underlying these changes in patients are limited, but studies in rodent models demonstrate alterations of dendrite complexity and spine density and function that could contribute to the morphological and functional alterations observed in humans. Rodent studies demonstrate region specific effects in chronic stress models of depression, including reductions in dendrite complexity and spine density in the hippocampus and prefrontal cortex (PFC) but increases in the basolateral amygdala and nucleus accumbens. Alterations of spine synapse connectivity in these regions are thought to contribute to the behavioral symptoms of depression, including disruption of cognition, mood, emotion, motivation, and reward. Studies of the mechanisms underlying these effects demonstrate a role for altered brain derived neurotrophic factor (BDNF) signaling that regulates synaptic protein synthesis. In contrast, there is evidence that chronic antidepressant treatment can block or reverse the spine synapse alterations caused by stress. Notably, the new fast acting antidepressant ketamine, which produces rapid therapeutic actions in treatment resistant MDD patients, rapidly increases spine synapse number in the PFC of rodents and reverses the effects of chronic stress. The rapid synaptic and behavioral actions of ketamine occur via increased BDNF regulation of synaptic protein synthesis. Together these studies provide evidence for a neurotophic and synaptogenic hypothesis of depression and treatment response and indicate that spine synapse connectivity in key cortical and limbic brain regions is critical for control of mood and emotion. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Duman, Catharine H AU - Duman CH AD - Laboratory of Molecular Psychiatry, Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06508, USA. FAU - Duman, Ronald S AU - Duman RS AD - Laboratory of Molecular Psychiatry, Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06508, USA. Electronic address: ronald.duman@yale.edu. LA - eng GR - R01 MH093897/MH/NIMH NIH HHS/United States GR - R01 MH105910/MH/NIMH NIH HHS/United States PT - Journal Article PT - Review DEP - 20150109 PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Antidepressive Agents) SB - IM MH - Animals MH - Antidepressive Agents/therapeutic use MH - Cerebral Cortex/pathology/physiopathology MH - Dendritic Spines/*physiology/ultrastructure MH - Depression/drug therapy/etiology/pathology/*physiopathology MH - Humans MH - Limbic System/pathology/physiopathology MH - Neurons/pathology MH - Stress, Psychological/complications/pathology/physiopathology MH - Synapses/*physiology PMC - PMC4497940 MID - NIHMS655074 OTO - NOTNLM OT - Antidepressant OT - Glutamate OT - Ketamine OT - Neurotrophic factor OT - Stress EDAT- 2015/01/15 06:00 MHDA- 2015/10/22 06:00 PMCR- 2016/08/05 CRDT- 2015/01/14 06:00 PHST- 2014/11/05 00:00 [received] PHST- 2015/01/07 00:00 [revised] PHST- 2015/01/08 00:00 [accepted] PHST- 2015/01/14 06:00 [entrez] PHST- 2015/01/15 06:00 [pubmed] PHST- 2015/10/22 06:00 [medline] PHST- 2016/08/05 00:00 [pmc-release] AID - S0304-3940(15)00027-0 [pii] AID - 10.1016/j.neulet.2015.01.022 [doi] PST - ppublish SO - Neurosci Lett. 2015 Aug 5;601:20-9. doi: 10.1016/j.neulet.2015.01.022. Epub 2015 Jan 9.